Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC

Abroad (travel likely)RecruitingPHASE2

Conditions

Recurrent or Metastatic Nasopharyngeal Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China
Contact: Study coordinator (Tian Xin Lin, PhD) · cheny778@mail.sysu.edu.cn · 86-0756-2528100
Contact: Study coordinator (Ming Yuan Chen, PhD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Recurrent or Metastatic Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China · Guangzhou, China

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Metastatic Nasopharyngeal Carcinoma · Recurrent Nasopharyngeal Carcinoma · Stage IV Nasopharyngeal Carcinoma AJCC v8

Abroad (travel likely)RecruitingPHASE2

Dublin, United States · Fremont, United States

Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal Carcinoma

Recurrent or Metastatic Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Zhuhai, China

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

Recurrent or Metastatic Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chongqing, China · Fuzhou, China